Found 7 matching trials
Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy PHASE2 To assess Minimal Residual Disease (MRD)-negative Complete Response (sCR) r...
Show More Location
University of California Irvine
Learn More & Join Trial
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis PHASE3 The AURORA Study is evaluating the safety, tolerability, and efficacy of an...
Show More Learn More & Join Trial
Descartes-08 for Patients With Systemic Lupus Erythematosus PHASE2 This is a Phase II study to evaluate the safety, tolerability and manufactu...
Show More Status
Active Not Recruiting
Location
Profound Research LLC
Learn More & Join Trial
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) PHASE2 This is a Phase IIb study to evaluate the safety and preliminary efficacy o...
Show More Status
Active Not Recruiting
Location
Profound Research
Learn More & Join Trial
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders PHASE1 Safety, tolerability and efficacy of Descarte-08 in children, adolescents a...
Show More Location
H01- Children's National Hospital
Learn More & Join Trial
Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma PHASE1 This Phase I study will test the safety and anti-myeloma activity of ascend...
Show More Location
The Center for Cancer and Blood Disorders
Learn More & Join Trial
Descartes-08 in Autoantibody Myositis PHASE2 This is a randomized, double-blind, placebo-controlled phase 2 study to eva...
Show More Location
University of California, Irvine
Learn More & Join Trial